NCT06570837

Brief Summary

detect the prevelance of anemic and non anemic iron deficiency in children with type 1 diabetes.assess the impact of anemic and non anemic iron deficiency in children with type 1 diabetes on their general condition

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
141

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 26, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

August 26, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

August 22, 2024

Last Update Submit

August 22, 2024

Conditions

Iron Deficiency, Anaemia in Children Type1DM

Outcome Measures

Primary Outcomes (1)

  • detect the prevelance of anemic and non anemic iron deficiency in children with type 1 diabetes.

    detect the prevelance of anemic and non anemic iron deficiency in children with type 1 diabetes.

    baseline

Secondary Outcomes (1)

  • assess the impact of anemic and non anemic iron deficiency in children with type 1 diabetes on their general condition

    baseline

Interventions

IronDIETARY_SUPPLEMENT

observation effect of iron dificincy

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

cross sectional

You may qualify if:

  • Primary School age children with type 1 diabetes from 6 years up to 12year .

You may not qualify if:

  • \- 1-All children with type1 diabetes less than 6 years and above 12 years. 2-Exclude other autoimmune diseases associated with diabetes mellitus (hypothyroidism, Addison disease , pernicious anemia, Celiac disease).
  • Any condition affecting iron metabolism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Rubenstein MD, Wall RT. Clinical use of beta-thromboglobulin levels in diagnosing and treating consumptive and immune thrombocytopenia. Am J Hematol. 1981 Jun;10(4):369-73. doi: 10.1002/ajh.2830100406.

    PMID: 6166192BACKGROUND

MeSH Terms

Conditions

Iron Deficiencies

Interventions

Iron

Condition Hierarchy (Ancestors)

Iron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Metals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Central Study Contacts

Esraa sayed, MD

CONTACT

01003908556esrasayed567@gmail.com

Shimaa kamal

CONTACT

01024982398

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

August 22, 2024

First Posted

August 26, 2024

Study Start

January 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

August 26, 2024

Record last verified: 2024-08